Agilon Health
177 hedge funds and large institutions have $8.05B invested in Agilon Health in 2023 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 85 increasing their positions, 41 reducing their positions, and 34 closing their positions.
210% more call options, than puts
Call options by funds: $49.5M | Put options by funds: $16M
107% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 41
5% more capital invested
Capital invested by funds: $7.67B → $8.05B (+$373M)
0.2% more ownership
Funds ownership: 4.27% → 4.47% (+0.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 185 → 177 (-8)
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$79.4M |
| 2 |
Morgan Stanley
New York
|
+$66.4M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$57.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$55.2M |
| 5 |
BlackRock
New York
|
+$9.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$21.4M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$17.3M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$15.3M |
| 4 |
TC
TwinBeech Capital
Purchase,
New York
|
-$13.4M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$12.3M |
AGL Hedge Fund Activity: Q3 2023 in Review
177 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q3 2023, worth a combined $8.05B — up 4.9% from $7.67B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of AGL and 27 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 85 added.
The largest buyer was Capital Research Global Investors, adding an estimated $79.4M. The largest seller was Renaissance Technologies, cutting an estimated $21.4M.
- 177 institutional investors held Agilon Health (AGL) as of Q3 2023, down from 185 in Q2 2023.
- Funds reported $8.05B of Agilon Health stock for Q3 2023, up 4.9% quarter-over-quarter.
- 27 funds opened new Agilon Health positions in Q3 2023 and 34 closed out, a net change of -7 holders.
- The largest Agilon Health buyer in Q3 2023 was Capital Research Global Investors, an estimated $79.4M added.
- The largest Agilon Health seller in Q3 2023 was Renaissance Technologies, an estimated $21.4M sold.
Based on aggregated 13F filings for Q3 2023.